Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides
SMTI Stock | USD 34.00 1.36 4.17% |
Under 55% of Sanara Medtech's traders are presently thinking to get in. The analysis of overall sentiment of trading Sanara Medtech stock suggests that some investors are interested at this time. Sanara Medtech's investing sentiment shows overall attitude of investors towards Sanara Medtech.
Sanara |
FORT WORTH, TX, Jan. 03, 2024 -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. , announced today that is has signed an exclusive license agreement with Tufts University to develop and commercialize patented technology covering 18 unique collagen peptides. Zach Fleming, Sanaras CEO stated, Sanara has established itself as a leader in bioactive collagen peptides with CellerateRX Surgica
Read at finance.yahoo.com
Sanara Medtech Fundamental Analysis
We analyze Sanara Medtech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sanara Medtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sanara Medtech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Sanara Medtech is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Sanara Medtech Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sanara Medtech stock to make a market-neutral strategy. Peer analysis of Sanara Medtech could also be used in its relative valuation, which is a method of valuing Sanara Medtech by comparing valuation metrics with similar companies.
Peers
Sanara Medtech Related Equities
MLSS | Milestone Scientific | 5.36 | ||||
NVST | Envista Holdings | 3.63 | ||||
MHUA | Meihua International | 3.23 | ||||
INFU | InfuSystems Holdings | 3.13 | ||||
POCI | Precision Optics, | 2.86 | ||||
ATR | AptarGroup | 2.40 | ||||
HAE | Haemonetics | 2.38 | ||||
KRMD | Repro Med | 1.22 | ||||
MMSI | Merit Medical | 0.81 | ||||
LMAT | LeMaitre Vascular | 0.60 | ||||
UTMD | Utah Medical | 0.27 | ||||
PDEX | Pro Dex | 0.07 | ||||
DXR | Daxor | 3.29 | ||||
ANGO | AngioDynamics | 3.94 |
Complementary Tools for Sanara Stock analysis
When running Sanara Medtech's price analysis, check to measure Sanara Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanara Medtech is operating at the current time. Most of Sanara Medtech's value examination focuses on studying past and present price action to predict the probability of Sanara Medtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanara Medtech's price. Additionally, you may evaluate how the addition of Sanara Medtech to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |